Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials

American Heart Journal

Volumn 163, Issue 2, 2012, Pages

  Sipahi, Ilke ^a   Chou, Josephine C ^a   Hyden, Marshall ^a   Rowland, Douglas Y ^b   Simon, Daniel I ^a   Fang, James C ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; HEART FAILURE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE CONDUCTION; HOSPITALIZATION; HUMAN; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS;

EID: 84856551618     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.11.014     Document Type: Article

References (32)

1. R. Rodeheffer, and M. Redfield Heart failure: diagnosis and evaluation J.G. Murphy, M.A. Lloyd, Mayo Clinic Cardiology 3rd ed. 2007 Mayo Clinic Scientific Press Rochester (Minn) 1101 1112
2. D.J. Bradley, E.A. Bradley, and K.L. Baughman Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials JAMA 289 2003 730 740 (Pubitemid 37430368)
3. F.A. McAlister, J. Ezekowitz, and N. Hooton Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review JAMA 297 2007 2502 2514 (Pubitemid 46953404)
4. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline J Card Fail 12 2006 10 38
5. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 2008 e350 e408
6. S.A. Hunt, W.T. Abraham, and M.H. Chin ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society Circulation 112 2005 e154 e235
7. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
8. FDA Food and Drug Administration Circulatory System Devices Panel Meeting: expanded indications for cardiac resynchronization therapy defibrillators based on MADIT-CRT Study 2010 http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/ MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM204607.pdf
9. M. Borenstein, L.V. Hedges, and J.P.T. Higgins Power Analysis for Meta-Analysis Introduction to meta-analysis 2009 John Wiley & Sons Chichester, UK 257 275
10. M.R. Bristow, L.A. Saxon, and J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
11. J.G. Cleland, J.C. Daubert, and E. Erdmann The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549 (Pubitemid 40517094)
12. A. Moss MADIT-CRT: sponsor's executive summary Food and Drug Administration 2010
13. A.J. Moss, W.J. Hall, and D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
14. A.S. Tang, G.A. Wells, and M. Talajic Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
15. R. Gervais, C. Leclercq, and A. Shankar Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial Eur J Heart Fail 11 2009 699 705
16. W. Zareba, H. Klein, and I. Cygankiewicz Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT) Circulation 123 2011 1061 1072
17. J. Rickard, D.J. Kumbhani, and E.Z. Gorodeski Cardiac resynchronization therapy in non-left bundle branch block morphologies Pacing Clin Electrophysiol 33 2010 590 595
18. C.A. Egoavil, R.T. Ho, and A.J. Greenspon Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials Heart Rhythm 2 2005 611 615 (Pubitemid 40724127)
19. E.C. Adelstein, and S. Saba Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization Am J Cardiol 103 2009 238 242
20. A. Wokhlu, R.F. Rea, and S.J. Asirvatham Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival Heart Rhythm 6 2009 1439 1447
21. K.C. Bilchick, S. Kamath, and J.P. DiMarco Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients Circulation 122 2010 2022 2030
22. K. Kaszala, and K.A. Ellenbogen When right may not be right: right bundle-branch block and response to cardiac resynchronization therapy Circulation 122 2010 1999 2001
23. P.B. Nery, A.C. Ha, and A. Keren Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: a systematic review Heart Rhythm 8 2011 1083 1087
24. M.J. Byrne, R.H. Helm, and S. Daya Diminished left ventricular dyssynchrony and impact of resynchronization in failing hearts with right versus left bundle branch block J Am Coll Cardiol 50 2007 1484 1490 (Pubitemid 47494595)
25. Garrigue S, Reuter S, Labeque JN, et al. Usefulness of biventricular pacing in patients with congestive heart failure and right bundle branch block. Am J Cardiol 2001;88:1436-41, A8. (Pubitemid 34008695)
26. N. Varma Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction Am J Cardiol 103 2009 1578 1585
27. D.J. Fox, A.P. Fitzpatrick, and N.C. Davidson Optimisation of cardiac resynchronisation therapy: addressing the problem of "non-responders" Heart 91 2005 1000 1002 (Pubitemid 41060000)
28. C.M. Yu, H. Lin, and Q. Zhang High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration Heart 89 2003 54 60 (Pubitemid 36044290)
29. J.G. Cleland, J. Ghosh, and N. Freemantle Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure? Nat Clin Pract Cardiovasc Med 1 2004 10 11 (Pubitemid 40823711)
30. I. Sipahi, T.P. Carrigan, and D.Y. Rowland Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials Arch Intern Med 171 2011 1454 1462
31. D.G. Strauss, R.H. Selvester, and G.S. Wagner Defining left bundle branch block in the era of cardiac resynchronization therapy Am J Cardiol 107 2011 927 934
32. P.W. Foley, K. Patel, and N. Irwin Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND study Heart 97 2011 1041 1047